Long QT Syndrome Clinical Trial
Official title:
Building of a Diagnostic/Prognostic Database by High-throughput Multiplexed Assays for Human ERG Variant Effects
Cardiac channelopathies induce severe heart rhythm or conduction disorders. Mutations of the KCNH2 gene, that encodes the human (h) ERG channel, is responsible for 30-40% of all cases of long QT syndrome (inherited LQT2). Besides, hERG is frequently responsible for off-target effects of several pharmacological agents (acquired LQT2). With the advent of Next Generation Sequencing, hundreds of new KCNH2 variants are accumulating in regional databases including those developed by french centers of references. Worldwide, we estimate there are more than 1000 variants for hERG channel. Unfortunately, many of these new variants appear to be of unknown functional significance in spite of available clinical and genetic information. Little is known on whether they affect the channel biophysical properties, its expression at the cell surface and/or its structure. Yet, this information is crucial to determine the real degree of pathogenicity of these variants, and therefore to make the proper diagnosis on inherited LQT2, counsel the patient for his treatment and improve the management of the patient's life. Our ambition is therefore to tackle this issue of variant significance by (i) launching a large-scale multi-functional evaluation of hERG variants, (ii) introducing for the first time a formatted large-scale pathogenicity annotation score for all variants that have been functionally evaluated by this multi-parametric approach, and (iii) regrouping all the relevant information collected in every French Regional centers of reference into a single National database hosted by an infrastructure that possesses enough flexibility for continuous data implementation and cross-referencing. The database will integrate the latest International guidelines for functional pathogenicity annotation. This project will also include the pharmacological characterization of several drugs susceptible to produce acquired LQT2 with variable severities. We aim to understand whether there are structural regions within hERG channel in which the introduction of a variant is more prone to increase the risk of acquired LQT2 or if, on the contrary, a set of variants may relatively protect some patients against LQT2-inducing drugs.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04169100 -
Novel Form of Acquired Long QT Syndrome
|
Phase 4 | |
Completed |
NCT01648205 -
Long-term Efficacy Study of Sodium Channel Blocker in LQT3 Patients
|
Phase 2 | |
Recruiting |
NCT04675788 -
Novel Approaches for Minimizing Drug-Induced QT Interval Lengthening
|
Phase 4 | |
Completed |
NCT05759962 -
Phase 1 Study of LQT-1213 in Healthy Adults
|
Phase 1 | |
Enrolling by invitation |
NCT05903313 -
A Study to Evaluate Accuracy and Validity of the Chang Gung ECG Abnormality Detection Software
|
||
Terminated |
NCT02439645 -
A Registry to Determine the Clinical and Genetic Risk Factors for Torsade De Pointes
|
||
Recruiting |
NCT00221832 -
Molecular Genetic Screening and Identification of Congenital Arrhythmogenic Diseases
|
N/A | |
Completed |
NCT04706104 -
QT Measurement Techniques and Anesthesia Management
|
||
Recruiting |
NCT04336644 -
Continuous Versus Intermittent cARdiac Electrical moNitorinG
|
N/A | |
Recruiting |
NCT02814981 -
Hydroxyzine and Risk of Prolongation of QT Interval
|
N/A | |
Completed |
NCT02425189 -
The Canadian National Long QT Syndrome Registry
|
||
Completed |
NCT02876380 -
Prospective Identification of Long QT Syndrome in Fetal Life
|
||
Completed |
NCT00399412 -
ECG Signal Collection From Long QT Syndrome, Wide QRS Complexes, Heart Failure, and Cardiac Resynchronization Patients
|
N/A | |
Completed |
NCT02513940 -
Influence of Testosterone Administration on Drug-Induced QT Interval Prolongation and Torsades de Pointes
|
Phase 4 | |
Completed |
NCT03182777 -
Safety of Local Dental Anesthesia in Patients With Cardiac Channelopathies
|
N/A | |
Completed |
NCT02441829 -
Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Renal Function
|
Phase 1 | |
Completed |
NCT01849003 -
Study of the Effect of GS-6615 in Subjects With LQT-3
|
Phase 1 | |
Completed |
NCT00316459 -
Study Evaluating the Effects of Multiple Oral Doses of ERB-041 on Cardiac Repolarization in Healthy Subjects
|
Phase 1 | |
Completed |
NCT00292032 -
Registry of Unexplained Cardiac Arrest
|
||
Recruiting |
NCT05348564 -
Comparing Direct vs Indirect Methods for Cascade Screening
|
N/A |